-
1
-
-
0029087201
-
Transport of immunoglobulinG and its subclasses across the in vitro-perfused human placenta
-
Malek A, Sager R, Zakher A, Schneider H. Transport of immunoglobulinG and its subclasses across the in vitro-perfused human placenta. Am J Obestet Gynecol 1995; 173:760-767.
-
(1995)
Am J Obestet Gynecol
, vol.173
, pp. 760-767
-
-
Malek, A.1
Sager, R.2
Zakher, A.3
Schneider, H.4
-
2
-
-
55849132798
-
Effects of structure of conventional anti-TNFs and certolizumab pegol on mode of action in rheumatoid arthritis
-
Nesbitt A, Fossati G, Brown D, et al. Effects of structure of conventional anti-TNFs and certolizumab pegol on mode of action in rheumatoid arthritis. Ann Rheum Dis 2007; 66 (Suppl 2):296.
-
(2007)
Ann Rheum Dis
, vol.66
, Issue.SUPPL. 2
, pp. 296
-
-
Nesbitt, A.1
Fossati, G.2
Brown, D.3
-
3
-
-
77952501401
-
Pregnancy outcomes in women exposed to etanercept: The OTIS autoimmune diseases in pregnancy project
-
Johnson DL, Jones KL, Chambers C. Pregnancy outcomes in women exposed to etanercept: the OTIS autoimmune diseases in pregnancy project. Arthritis Rheum 2008; 58 (Suppl 9):S682.
-
(2008)
Arthritis Rheum
, vol.58
, Issue.SUPPL. 9
-
-
Johnson, D.L.1
Jones, K.L.2
Chambers, C.3
-
4
-
-
79954988597
-
Pregnancy outcomes in women exposed to adalimumab
-
Johnson D, Jones K, Chambers C. Pregnancy outcomes in women exposed to adalimumab. Can J Gastroenterol 2009; 23 (Suppl SA):34.
-
(2009)
Can J Gastroenterol
, vol.23
, Issue.SUPPL. SA
, pp. 34
-
-
Johnson, D.1
Jones, K.2
Chambers, C.3
-
5
-
-
65649134752
-
A safety assessment of tumor necrosis factor antagonists during pregnancy: A review of the Food and Drug Administration database
-
Carter JD, Ladhani A, Ricca LR, et al. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol 2009; 36:635-641.
-
(2009)
J Rheumatol
, vol.36
, pp. 635-641
-
-
Carter, J.D.1
Ladhani, A.2
Ricca, L.R.3
-
6
-
-
58749115377
-
Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature
-
Berthelot JM, De Bandt M, Goupille P, et al. Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature. Joint Bone Spine 2009; 76:28-34.
-
(2009)
Joint Bone Spine
, vol.76
, pp. 28-34
-
-
Berthelot, J.M.1
De Bandt, M.2
Goupille, P.3
-
7
-
-
33745634096
-
Cytokines and pregnancy in rheumatic disease
-
1stensen M, Fö rger F, Villiger PM. Cytokines and pregnancy in rheumatic disease. Ann N Y Acad Sci 2006; 1069:353-363.
-
(2006)
Ann N y Acad Sci
, vol.1069
, pp. 353-363
-
-
Istensen, M.F.1
-
8
-
-
11144254079
-
Tumor necrosis factor receptor 1 expression and early spontaneous abortion
-
Yu XW, Yan CF, Jin HL, Li X. Tumor necrosis factor receptor 1 expression and early spontaneous abortion. Int J Gynecol and Obstet 2005; 88: 77-79.
-
(2005)
Int J Gynecol and Obstet
, vol.88
, pp. 77-79
-
-
Yu, X.W.1
Yan, C.F.2
Jin, H.L.3
Li, X.4
-
9
-
-
58249141891
-
Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF
-
Winger EE, Reed JL, Ashoush S, et al. Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol 2009; 61:113-120.
-
(2009)
Am J Reprod Immunol
, vol.61
, pp. 113-120
-
-
Winger, E.E.1
Reed, J.L.2
Ashoush, S.3
-
10
-
-
59249087444
-
Clinical experience with intravenous immunoglobulin and TNF - A inhibitor therapies for recurrent pregnancy loss
-
Sills ES, Walsh DJ, Shkrobot LV, et al. Clinical experience with intravenous immunoglobulin and TNF-a inhibitor therapies for recurrent pregnancy loss. Ulster Med J 2009; 78:57-58.
-
(2009)
Ulster Med J
, vol.78
, pp. 57-58
-
-
Sills, E.S.1
Walsh, D.J.2
Shkrobot, L.V.3
-
11
-
-
77958094698
-
First successful pregnancy after addition of enoxaparin to sildenafil and etanercept immunotherapy in woman with fifteen failed IVF cycles: Case report
-
Jerzak M, Niemiec T, Nowakowska A, et al. First successful pregnancy after addition of enoxaparin to sildenafil and etanercept immunotherapy in woman with fifteen failed IVF cycles: case report. Am J Reprod Immunol 2010; 64:93-96.
-
(2010)
Am J Reprod Immunol
, vol.64
, pp. 93-96
-
-
Jerzak, M.1
Niemiec, T.2
Nowakowska, A.3
-
12
-
-
76649111042
-
Treatment of psoriasis with anti-TNF drugs during pregnancy: Case report and review of the literature
-
Puig L, Barco D, Alomar A. Treatment of psoriasis with anti-TNF drugs during pregnancy: case report and review of the literature. Dermatology 2010; 220:71-76.
-
(2010)
Dermatology
, vol.220
, pp. 71-76
-
-
Puig, L.1
Barco, D.2
Alomar, A.3
-
13
-
-
67650992265
-
Absence of Infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery
-
Kane S, Ford J, Cohen R, Wagner C. Absence of Infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery. J Clin Gastroenterol 2009; 43:613-616.
-
(2009)
J Clin Gastroenterol
, vol.43
, pp. 613-616
-
-
Kane, S.1
Ford, J.2
Cohen, R.3
Wagner, C.4
-
14
-
-
34848824250
-
Infliximab levels in infants born to women with inflammatory bowel disease
-
959
-
Mahadevan U, Terdiman JP, Church J, et al. Infliximab levels in infants born to women with inflammatory bowel disease. Gastroenterology 2007; 132 (Suppl 1):A 144:959.
-
(2007)
Gastroenterology
, vol.132
, Issue.SUPPL. 1
-
-
Mahadevan, U.1
Terdiman, J.P.2
Church, J.3
-
15
-
-
33749434256
-
Case Report: Evidence for Transplacental Transfer of Maternally Administered Infliximab to the Newborn
-
DOI 10.1016/j.cgh.2006.07.018, PII S1542356506007750
-
Vasiliauskas EA, Church JA, Silverman, et al. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 2006; 4:1255-1258. (Pubitemid 44512222)
-
(2006)
Clinical Gastroenterology and Hepatology
, vol.4
, Issue.10
, pp. 1255-1258
-
-
Vasiliauskas, E.A.1
Church, J.A.2
Silverman, N.3
Barry, M.4
Targan, S.R.5
Dubinsky, M.C.6
-
16
-
-
0035164357
-
Complementary effects of TNF and lymphotoxin on the formation of germinal center and follicular dendritic cells
-
Wang Y, Wang J, Sun Y, et al. Complementary effect of TNF and lymphotoxin on the formation of germinal center and follicular dendritic cells. J Immunol 2001; 166:330-337. (Pubitemid 32038449)
-
(2001)
Journal of Immunology
, vol.166
, Issue.1
, pp. 330-337
-
-
Wang, Y.1
Wang, J.2
Sun, Y.3
Wu, Q.4
Fu, Y.-X.5
-
17
-
-
77958150896
-
Case report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease
-
Cheent K, Nolan J, Shariq S, et al. Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohn's Colitis 2010; 4:603-605.
-
(2010)
J Crohn's Colitis
, vol.4
, pp. 603-605
-
-
Cheent, K.1
Nolan, J.2
Shariq, S.3
-
18
-
-
75749106673
-
A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment
-
Umeda N, Ito S, Hayashi T, et al. A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment. Intern Med 2010; 49:187-189.
-
(2010)
Intern Med
, vol.49
, pp. 187-189
-
-
Umeda, N.1
Ito, S.2
Hayashi, T.3
-
19
-
-
78650170917
-
Conception and course of eight pregnancies in five women on TNF blocker etanercept treatment
-
[Epub ahead of print]
-
Rump JA, Schö nborn H. Conception and course of eight pregnancies in five women on TNF blocker etanercept treatment. Z Rheumatol 2010 [Epub ahead of print].
-
(2010)
Z Rheumatol
-
-
Rump, J.A.1
Schönborn, H.2
-
20
-
-
70449706430
-
Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: Drug levels in maternal serum, cord blood, breast milk and the infant's serum
-
Murashima A, Watanabe N, Ozawa N, et al. Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum. Ann Rheum Dis 2009; 68:1793-1794.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1793-1794
-
-
Murashima, A.1
Watanabe, N.2
Ozawa, N.3
-
21
-
-
77949884124
-
Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: A comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR
-
Suzuki T, Ishii-Watabe A, Tada M, et al. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR. J Immunol 2010; 184:1968-1976.
-
(2010)
J Immunol
, vol.184
, pp. 1968-1976
-
-
Suzuki, T.1
Ishii-Watabe, A.2
Tada, M.3
-
25
-
-
84856720051
-
Certolizumab pegol use in pregnancy: Low levels detected in cord blood
-
Nov Suppl Annual Congress Abstract 718
-
Wolf D, Mahadevan U. Certolizumab pegol use in pregnancy: low levels detected in cord blood. Arthritis Rheum 2010; Nov Suppl, Annual Congress, Abstract 718.
-
(2010)
Arthritis Rheum
-
-
Wolf, D.1
Mahadevan, U.2
-
26
-
-
77957281706
-
Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis
-
Villiger PM, Caliezi G, Cottin V, et al. Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis. Ann Rheum Dis 2010; 69:1842-1844.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1842-1844
-
-
Villiger, P.M.1
Caliezi, G.2
Cottin, V.3
-
30
-
-
33749999729
-
The effects of rituximab treatment during pregnancy on a neonate
-
Friedrichs B, Tiemann M, Salwender H, et al. The effects of rituximab treatment during pregnancy on a neonate. Haematologica 2006; 91:1426-1427. (Pubitemid 44569825)
-
(2006)
Haematologica
, vol.91
, Issue.10
, pp. 1426-1427
-
-
Friedrichs, B.1
Tiemann, M.2
Salwender, H.3
Verpoort, K.4
Wenger, M.K.5
Schmitz, N.6
-
31
-
-
33746462344
-
Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy
-
DOI 10.1016/S1470-2045(06)70797-5, PII S1470204506707975
-
Decker M, Rothermundt C, Hollä nder G, et al. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncol 2006; 7:693-694. (Pubitemid 44123581)
-
(2006)
Lancet Oncology
, vol.7
, Issue.8
, pp. 693-694
-
-
Decker, M.1
Rothermundt, C.2
Hollander, G.3
Tichelli, A.4
Rochlitz, C.5
-
32
-
-
47349116535
-
Rituximab administration in third trimester pregnancy suppress neonatal B-cell development
-
Klink DT, Van Elburg RM, Schreurs MWJ, Van Well GTJ. Rituximab administration in third trimester pregnancy suppress neonatal B-cell development. Clin Dev Immunol 2008; 2008:271363.
-
(2008)
Clin Dev Immunol
, vol.2008
, pp. 271363
-
-
Klink, D.T.1
Van Elburg, R.M.2
Mwj, S.3
Van Well Gtj4
-
33
-
-
69549092122
-
Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab
-
Pellkofer HL, Suessmair C, Schulze A, et al. Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab. Multiple Sclerosis 2009; 15:1006-1008.
-
(2009)
Multiple Sclerosis
, vol.15
, pp. 1006-1008
-
-
Pellkofer, H.L.1
Suessmair, C.2
Schulze, A.3
-
34
-
-
58549103095
-
Rituximab combined with chemotherapy for lymphoma during pregnancy
-
Rey J, Coso D, Roger V, et al. Rituximab combined with chemotherapy for lymphoma during pregnancy. Leuk Res 2009; 33:e8-e9.
-
(2009)
Leuk Res
, vol.33
-
-
Rey, J.1
Coso, D.2
Roger, V.3
-
35
-
-
79955013746
-
Successful pregnancy after rituximab in a woman with recurrent in vitro fertilisation failures and antiphospholipid antibody
-
Ng CT, O'Neil M, Walsh D, et al. Successful pregnancy after rituximab in a woman with recurrent in vitro fertilisation failures and antiphospholipid antibody. Ir J Med Sci 2009; 178:531-533.
-
(2009)
Ir J Med Sci
, vol.178
, pp. 531-533
-
-
Ng, C.T.1
O'Neil, M.2
Walsh, D.3
-
36
-
-
79551653340
-
Rituximab and pregnancy: Safe before conception? A case report and a review of the literature
-
Abstract AB0229
-
Ton E, Tekstra J, Hellman PM, Bijlsma JWJ. Rituximab and pregnancy: safe before conception? A case report and a review of the literature. Ann Rheum Dis 2009; 68 (Abstract AB0229).
-
(2009)
Ann Rheum Dis
, vol.68
-
-
Ton, E.1
Tekstra, J.2
Hellman, P.M.3
Jwj, B.4
-
37
-
-
77955296598
-
Apparent safe use of a single dose rituximab for recalcitrant atopic dermatitis in the first trimester of a twin pregnancy
-
Ponte P, Lopes MJP. Apparent safe use of a single dose rituximab for recalcitrant atopic dermatitis in the first trimester of a twin pregnancy. J Am Acad Dermatol 2010; 63:355-356.
-
(2010)
J Am Acad Dermatol
, vol.63
, pp. 355-356
-
-
Ponte, P.1
Mjp, L.2
-
38
-
-
79953125573
-
Pregnancy outcomes following maternal exposure to rituximab
-
[Epub ahead of print]
-
Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes following maternal exposure to rituximab. Blood 2010 [Epub ahead of print].
-
(2010)
Blood
-
-
Chakravarty, E.F.1
Murray, E.R.2
Kelman, A.3
Farmer, P.4
-
39
-
-
58849146669
-
Rituximab (MabThera) therapy and safety management. clinical tool guide
-
Pham T, Fautrel B, Gottenberg JE, et al. Rituximab (MabThera) therapy and safety management. clinical tool guide. Joint Bone Spine 2008; 75 (Suppl 1):S1-S99.
-
(2008)
Joint Bone Spine
, vol.75
, Issue.SUPPL. 1
-
-
Pham, T.1
Fautrel, B.2
Gottenberg, J.E.3
-
42
-
-
84926433002
-
First experiences with pregnancies in RA patients receiving tocilizumab therapy
-
Abstract 384 Nov Suppl: Annual Congress
-
Rubbert-Roth A, Goupille PM, Moosavi S, Hou A. First experiences with pregnancies in RA patients receiving tocilizumab therapy. Arthritis Rheum 2010; Nov Suppl: Annual Congress, Abstract 384.
-
(2010)
Arthritis Rheum
-
-
Rubbert-Roth, A.1
Goupille, P.M.2
Moosavi, S.3
Hou, A.4
|